Yijuang Chern

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

ROS-HIF1α-driven glycolytic reprogramming sustains ATP production in Huntington's disease.

ROS-HIF1α-driven glycolytic reprogramming sustains ATP production in Huntington's disease.

Journal: Neurobiology of disease

Published: April 26, 2026

Galectins as stress-integrating regulators of neuroimmune signaling and proteinopathy in the central nervous system.

Galectins as stress-integrating regulators of neuroimmune signaling and proteinopathy in the central nervous system.

Journal: Neurobiology of disease

Published: January 24, 2026

ENT1 inhibitor J4 restores cognitive function and white-matter integrity in a mouse model of tuberous sclerosis complex.

ENT1 inhibitor J4 restores cognitive function and white-matter integrity in a mouse model of tuberous sclerosis complex.

Journal: Journal of biomedical science

Published: December 11, 2025

Protocol for metabolite extraction and sample preparation from primary astrocytes for mass spectrometry-based metabolomic analysis.

Protocol for metabolite extraction and sample preparation from primary astrocytes for mass spectrometry-based metabolomic analysis.

Journal: STAR protocols

Published: December 11, 2025

Scanning Bessel beam microscopy with a protected and corrective objective for solvent-cleared large samples.

Scanning Bessel beam microscopy with a protected and corrective objective for solvent-cleared large samples.

Journal: iScience

Published: November 23, 2025

Berbamine hydrochloride as a brain penetrant galectin 3 inhibitor in a model of Huntington's disease.

Berbamine hydrochloride as a brain penetrant galectin 3 inhibitor in a model of Huntington's disease.

Journal: Brain : a journal of neurology

Published: June 30, 2025

Preclinical Evaluation of a Novel Molecule Targeting Nucleoside Homeostasis to Restore Energy Metabolism and Cognitive Function in Alzheimer's Disease.

Preclinical Evaluation of a Novel Molecule Targeting Nucleoside Homeostasis to Restore Energy Metabolism and Cognitive Function in Alzheimer's Disease.

Journal: Pharmacology research & perspectives

Published: March 08, 2025

Anti-seizure potential of J4, an equilibrative nucleoside transporter 1 inhibitor, in a mouse model of tuberous sclerosis complex in response to pentylenetetrazol.

Anti-seizure potential of J4, an equilibrative nucleoside transporter 1 inhibitor, in a mouse model of tuberous sclerosis complex in response to pentylenetetrazol.

Journal: Cell & bioscience

Published: March 03, 2025

Correction: Adenosine A2A Receptor Up-Regulates Retinal Wave Frequency via Starburst Amacrine Cells in the Developing Rat Retina.

Correction: Adenosine A2A Receptor Up-Regulates Retinal Wave Frequency via Starburst Amacrine Cells in the Developing Rat Retina.

Journal: PloS one

Published: November 20, 2024

The role of adiponectin-AMPK axis in TDP-43 mislocalization and disease severity in ALS.

The role of adiponectin-AMPK axis in TDP-43 mislocalization and disease severity in ALS.

Journal: Neurobiology of disease

Published: September 09, 2024

Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives.

Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives.

Journal: Neurobiology of disease

Published: August 18, 2024

Corrigendum to "Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model" [Brain Behav. Immun. 120 (2024) 413-429].

Corrigendum to "Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model" [Brain Behav. Immun. 120 (2024) 413-429].

Journal: Brain, behavior, and immunity

Published: August 18, 2024

Showing 1-12 of 88

Last Updated: 09/26/2026